Literature DB >> 18763051

Cardiovascular magnetic resonance and thalassaemia.

J P Carpenter1, D J Pennell.   

Abstract

Mesh：

Year:  2008        PMID： 18763051     DOI： 10.1007/s10554-008-9358-5

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN： 1569-5794            Impact factor:   2.357


× No keyword cloud information.
  26 in total

1.  Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major.

Authors:  Caterina Borgna-Pignatti; Maria Domenica Cappellini; Piero De Stefano; Giovanni Carlo Del Vecchio; Gian Luca Forni; Maria Rita Gamberini; Roberta Ghilardi; Antonio Piga; Maria Antonietta Romeo; Huaqing Zhao; Avital Cnaan
Journal:  Blood       Date:  2005-12-22       Impact factor: 22.113

2.  Intercentre reproducibility of magnetic resonance T2* measurements of myocardial iron in thalassaemia.

Authors:  Mark A Westwood; David N Firmin; Matta Gildo; Galanello Renzo; Gotsis Stathis; Karagiorga Markissia; Berdoukas Vasili; Dudley J Pennell
Journal:  Int J Cardiovasc Imaging       Date:  2005-10       Impact factor: 2.357

3.  Histochemical studies of the myocardium and conduction system in acquired iron-storage disease.

Authors:  P F Schellhammer; M A Engle; J W Hagstrom
Journal:  Circulation       Date:  1967-04       Impact factor: 29.690

4.  Cardiac involvement in thalassemia intermedia: a multicenter study.

Authors:  A Aessopos; D Farmakis; M Karagiorga; E Voskaridou; A Loutradi; A Hatziliami; J Joussef; J Rombos; D Loukopoulos
Journal:  Blood       Date:  2001-06-01       Impact factor: 22.113

5.  Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance.

Authors:  Lisa J Anderson; Mark A Westwood; Sally Holden; Bernard Davis; Emma Prescott; Beatrix Wonke; John B Porter; J Malcolm Walker; Dudley J Pennell
Journal:  Br J Haematol       Date:  2004-11       Impact factor: 6.998

6.  Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.

Authors:  G M Felker; R E Thompson; J M Hare; R H Hruban; D E Clemetson; D L Howard; K L Baughman; E K Kasper
Journal:  N Engl J Med       Date:  2000-04-13       Impact factor: 91.245

Review 7.  Heart disease in thalassemia intermedia: a review of the underlying pathophysiology.

Authors:  Athanasios Aessopos; Maria Kati; Dimitrios Farmakis
Journal:  Haematologica       Date:  2007-05       Impact factor: 9.941

8.  Serum erythropoietin and erythropoiesis in high- and low-fetal hemoglobin beta-thalassemia intermedia patients.

Authors:  R Galanello; S Barella; M P Turco; N Giagu; A Cao; F Dore; N L Liberato; R Guarnone; G Barosi
Journal:  Blood       Date:  1994-01-15       Impact factor: 22.113

9.  Noninvasive assessment of systolic and diastolic left ventricular function in patients with chronic severe anemia: a combined M-mode, two-dimensional, and Doppler echocardiographic study.

Authors:  V K Bahl; O P Malhotra; D Kumar; R Agarwal; K C Goswami; R Bajaj; S Shrivastava
Journal:  Am Heart J       Date:  1992-12       Impact factor: 4.749

10.  A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload.

Authors:  Mark Westwood; Lisa J Anderson; David N Firmin; Peter D Gatehouse; Clare C Charrier; Beatrix Wonke; Dudley J Pennell
Journal:  J Magn Reson Imaging       Date:  2003-07       Impact factor: 4.813
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.